H.C. Wainwright Upgrades Rapt Therapeutics on New Licensing Deal
Rapt Therapeutics receives a boost as H.C. Wainwright upgrades it to Buy following a new licensing agreement for an anti-immunoglobulin E monoclonal antibody.
Topic
Licensing
A collection of 3 issues
Qualcomm Cleared in Arm License Dispute; Nuvia Case Ends in Mistrial
Qualcomm was found not to have breached its Arm license, while the jury deadlocked on Nuvia's case, leading to a mistrial. Discover more about this semiconductor legal battle.
Qualcomm's $1.4B Nuvia Acquisition Sparks Legal Clash with Arm Holdings
Qualcomm's $1.4 billion acquisition of Nuvia in March 2021 has triggered a legal dispute with Arm Holdings over licensing agreements in the semiconductor industry.